N/A N=20 Radiological Evaluation of Radiesse Implantation in the Hands
Volume Loss in the Dorsum of the Hand
Primary: Number of Participants With X-ray of Either Hand With Bone Obscuration at Month 1 — 0; 0 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=92 Effectiveness and Safety of Restylane Lyft With Lidocaine in the Dorsal Hand
Volume Deficit in the Hand
Primary: Responder Rate Using Validated Hand Grading Scale — 73; 18; 12; 67 Participants — p=<0.0001
N/A N=109 Safety and Efficacy of Restylane Vital for Skin Rejuvenation of Dorsal Hands
Dorsal Hands
Primary: The Efficacy of Restylane Vital on Skin Structure Compared to no Treatment Using a Validated Scale. — 0.85; 2.17 units on a scale
N/A N=256 Radiesse® Safety Study For the Treatment of Hands
Volume Loss in the Dorsum of the Hand
Primary: Proportion of Subjects With Device-and/or Injection-related Severe Treatment-emergent Adverse Events (TEAEs) in the Grade 4 Hands Group Versus the Grade 2-3 Hands Group…
N/A N=101 Evaluation of Radiesse® Dermal Filler for Hand Rejuvenation
Aging Hands
Primary: Mean Change on Busso Hand Volume Severity Scale (BHVSS), by Hand — 2.54; 2.44; 1.72; 2.44 units on a scale — p=< 0.0001
N/A N=118 Evaluation of Radiesse® Dermal Filler for Hand Treatment
Aging Hands
Primary: Mean Change on Merz Hand Grading Scale (MHGS), by Hand — 2.6; 2.6; 1.5; 2.6 units on a scale — p=<0.0001
N/A N=90 Comparing Pain, Safety and Effectiveness of Restylane Skinboosters Vital Lido and Vital Without Lido in Dorsal Hand
Skin Aging of Dorsal Hands
Primary: The Within-subject Difference in VAS Score (Restylane Skinboosters Vital Lidocaine- Restylane Vital) at End of Injection (T0). — 32.5; 46.9 score on a scale — p=<0.0001
N/A N=115 The Volumizing Effect of Juvéderm VOLUMA® in the Mid-Face
Age-related Volume Deficit in the Mid-face
Primary: Subject Experience Measured by Patient Satisfaction Questionnaire — 1.94; 1.62; 1.51 Units on a scale
Early Phase 1 N=20 Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients
Systemic Sclerosis
Primary: Raynaud's Condition Scale — 5; 5; 6.5; 3 score on a scale — p=0.256
N/A N=16 Jowl Improvement With Injectable Fillers
Jowls
Primary: Blinded Physician Jawline Rating Scale (JRS) Assessment on Scale of 0 to 4 at Baseline Versus 4 Weeks After Last Injection. — 2.214; 2.071; 1.857; 1.857 score on a scale…
N/A N=29 JUVÉDERM VOLUMA® to Enhance the Appearance of the Asian Nose
Asian Nose Enhancement
Primary: Percentage of Participants With a ≥ 1 Grade Improvement on the Assessment of Aesthetic Improvement Scale (AAIS) as Assessed by the Central Evaluating Physician at Day…
N/A N=110 Saypha® Volume LIdocaine in Nasolabial Folds
Moderate to Severe Nasolabial Folds
Primary: Responder Rate in Reduction of Nasolabial Folds — 34; 39; 73 Participants
N/A N=168 Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
Midface Volume Deficit
Primary: Percentage of Responders — 80; 87.2; 76.7 percentage of subjects
Phase 3 N=168 JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population
Temple Hollowing
Primary: Number of Participants With Adverse Events — 23; 59; 1; 2 Participants
Phase 4 N=53 A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT®™ With Lidocaine for Dynamic Radial Cheek Line Skin Depressions
Cheek Line Depressions
Primary: Percentage of Participants by Improvement Rating (Improved and Not Improved) of Their Dynamic Radial Cheek Lines as Assessed by the Participant Using the Global…
N/A N=60 Pan Facial Volume Restoration
Volume Loss (Soft Tissue Ptosis or Atrophy )
Primary: Mean Change From Baseline in Volume Loss Assessment — -0.8 Score on a scale
Phase 4 N=25 Changing in Skin Physiology After Microdroplet Placement of Stabilized Hyaluronic Acid in Aging Faces
Aging
Primary: Hydration Level — 53.19; 46.75 AU (arbitrary unit) — p=<0.05
N/A N=205 Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
Midface Volume Deficit
Primary: Percentage of Participants With 1 Point Improvement From Baseline on the Medicis Midface Volume Scale (MMVS) as Measured by the Blinded Evaluator at Month 12 — 68.8…
N/A N=36 Durolane SJ for Treatment of Rhizarthrosis
Rhizarthrosis
Primary: Change From Baseline in Pain Measured by the VAS Scale — -2.00 units on a scale
N/A N=27 Hands on - a Hand Care Guide in Systemic Sclerosis
Scleroderma
Primary: Cochin Hand Functional Scale — 19.24 units on a scale
N/A N=60 A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula
Age-related Volume Deficit in the Mid-face
Primary: Change From Baseline in Mid-Face Volume Deficit Scale (MFVDS) Score — 3.5; 3.5; -1.8; -1.9 score on a scale
N/A N=103 Safety and Efficacy of Juvederm® VOLUMA™ for Correction of Mid-face Volume Deficiency
Mid-face Volume Deficiency
Primary: Percentage of Participants With a ≥ 1 Point Improvement From Baseline in the Subject's Global Aesthetic Improvement Scale (GAIS) at Week 4 — 97.06 percentage of…
N/A N=11 Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal Fillers
Volume Deficiency of the Midface
Primary: Assess and Compare Tissue Aggregation and Visualization of Hyaluronic Acid Fillers by Investigator Using Ultrasound — 10; 1; 7; 9 Participants
N/A N=31 Thumb Osteoarthritis: A Cross-Sectional Study of Mechanisms
Carpometacarpal Osteoarthritis
Primary: Australian Canadian OA Hand Index (AUSCAN) — 3.3; 1.3; 2.0; 1.6 score on a scale
N/A N=31 Handgrip Exercise for Arteriovenous Fistula Maturation
Chronic Kidney Disease
Primary: Venous Diameter. — 5.78; 6.42 mm
N/A N=12 Repair of Soft Tissue Defect of the Finger Using the Heterodigital Neurocutaneous Island Flap
Sensory Reconstruction of the Volar Aspect of the Finger · The Heterodigital Neurocutaneous Island Flap
Primary: Discriminatory Sensation of the Flap — 8.3 mm
N/A N=11 A Prospective Evaluation of Infraorbital Filler Injection
Dermal Filler · Rejuvenation
Primary: Volumetric Change in Infraorbital Treatment Baseline to Each Post-intervention Timepoint Day 14, Day 30, and Day 90 — -0.026; -0.065; -0.108 cc
N/A N=62 Factors Associated With Radiographic Pathophysiology for Trapeziometacarpal Arthrosis in Patients Not Seeking Care for This Condition
Trapeziometacarpal Arthrosis
Primary: Factors Associated With Eaton Classification of Trapeziometacarpal Arthrosis: Age — 61; 66; 75 Years
Phase 1 N=20 Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy
HIV Facial Lipoatrophy
Primary: Number of Participants Rated Very Much Improved on the Global Aesthetic Improvement Scale (GAIS) by Prinicple Investigator — 19 participants
N/A N=10 Coronal Mode Ultrasound Guided Hemodialysis Cannulation: Comparison With Standard Cannulation Technique
Arteriovenous Fistula, Cannulation
Primary: Infiltration Due to Dialysis Access Cannulation — 5; 7 infiltration events